Protalix Biotherapeutics Inc (PLX)

Protalix Biotherapeutics Inc (PLX) is a Biotechnology company in the Healthcare sector listed on the AMEX.

As of Oct 23, 2026: market cap $210M; returns 1 day -0.8%, 1 week -2.7%, 1 year +10.4%.

Protalix Biotherapeutics Inc. is a biopharmaceutical company focused on the discovery, development, production, and commercialization of recombinant therapeutic proteins for rare diseases, leveraging its proprietary ProCellEx® plant cell-based protein expression system.

Groups PLX belongs to

• Biotechnology
• Biopharmaceutical
• Rare Diseases
• Commercial Stage Biotech
• Healthcare
• Life Sciences
• Pharmaceuticals
• Israel

PLX financial model: income statement, cash flow and balance sheet